Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 3,072	$ 3,889	$ 2,686
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	1,633	1,577	1,551
Loss on impairments	357	0	0
Share-based compensation	123	101	110
Gains on disposals from discontinued operations, businesses and long-lived assets, net	(66)	(1,422)	(119)
Deferred tax (benefit) expense	(64)	(63)	99
Loss (income) from equity method investments	17	0	(55)
Pension and other postretirement benefits net periodic benefit cost	31	30	61
Non-cash operating lease costs	293	273	318
Other items, net	68	45	11
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Accounts receivable, net	(164)	(226)	(404)
Inventories	(60)	(655)	(439)
Accounts payable	144	403	539
Operating lease liabilities	(276)	(269)	(299)
Other assets	25	(45)	(124)
Other liabilities	(72)	205	95
Pension and other postretirement benefits contributions	(44)	(43)	(51)
Net cash provided by operating activities	5,017	3,800	3,979
Cash Flows from Investing Activities:
Purchases of property, plant and equipment	(1,817)	(1,523)	(1,554)
Acquisitions, net of cash acquired	(640)	(3,253)	(1,494)
Proceeds from divestitures and disposals of long-lived assets	104	3,827	387
Dividends received from equity method investments	44	36	32
Settlements of derivatives	(1)	(11)	0
Deferred divestiture consideration received	6	52	120
Other investing activities, net	(87)	(45)	(4)
Net cash used in investing activities	(2,391)	(917)	(2,513)
Cash Flows from Financing Activities:
Proceeds from debt issuances	3,163	38	0
Payments on debt	(1,462)	(364)	(1,183)
Settlements of derivatives	7	(11)	(37)
Payments of finance lease obligations	(26)	(28)	(29)
Deferred and contingent acquisition consideration paid	(22)	(24)	(29)
Dividends paid	(940)	(917)	(906)
Distributions to noncontrolling and redeemable noncontrolling interests	(35)	(23)	(40)
Transactions involving noncontrolling interests	(2)	(3)	0
Repurchases of common stock	(3,067)	(1,178)	(896)
Proceeds from exercise of stock options	4	11	13
Net cash used in financing activities	(2,380)	(2,499)	(3,107)
Effect of exchange rate changes on cash and cash equivalents	208	(231)	(297)
Increase/(decrease) in cash and cash equivalents	454	153	(1,938)
Cash and cash equivalents at the beginning of year	5,936	5,783	7,721
Cash and cash equivalents at the end of year	6,390	5,936	5,783
Supplemental cash flow information:
Cash paid for interest (including finance leases)	418	329	340
Cash paid for income taxes	959	1,043	642
Reconciliation of cash and cash equivalents
Cash and cash equivalents presented in the Consolidated Balance Sheets	6,341	5,936	5,783
Cash and cash equivalents included in assets held for sale	49	0	0
Total cash and cash equivalents presented on the Consolidated Statements of Cash Flows	$ 6,390	$ 5,936	$ 5,783